NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

When it comes to the subject of market cap, right now, with no real earnings our market cap is purely based on the potential investors believe the company has. Data from the trial that's positive will certainly increase what people think, perhaps to the point where our market cap is a much as a few billion dollars.

When people speak or double or triple digit billion dollar market caps for the company, I believe it should be based largely on earnings. For companies market caps based on earnings the P/E ratio usually ranges from a low of 10 to a high of 30.

If you believe as I do, the idea that the company can earn $10 billion a year if the vaccines prove to work in a few cancers, you should agree we could have a market cap somewhere between $100 and $300 billion. This doesn't happen instantaneously, but I'd have to believe that at some point between say 3 and 10 years post approval it should happen. The thing is, if more cancers are routinely added it won't stop at $10 billion in earnings. I can't say how high it could go, perhaps others would care to chime in, but if the company isn't bought out, I believe it has this sort of potential.

Gary